General practitioner assessment of stage and performance status in lung cancer patients at a population level: Implications for prognosis and radiotherapy needs analyses

Tyldesley, Scott; Roques, Tom; Erridge, Sara

doi:10.1016/j.lungcan.2007.03.024

Cited by 10 publications

(7 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A previous study in British Columbia has shown that in 2002, the crude referral rate of lung cancer patients to BCCA within 6 months of diagnosis was 67%. 18 In this study, surveys were sent to family physicians enquiring about stage and PS. The nonreferred group was characterized by two groups of patients, those with localized disease and good PS who received surgery, and those with metastatic disease and poor PS who received BSC.…”

Section: Discussionmentioning

confidence: 99%

Stage III Non–Small-Cell Lung Cancer: Population-Based Patterns of Treatment in British Columbia, Canada

Vinod

Wai

Alexander

et al. 2012

Journal of Thoracic Oncology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Stage III Non–Small-Cell Lung Cancer: Population-Based Patterns of Treatment in British Columbia, Canada

Vinod

Wai

Alexander

et al. 2012

Journal of Thoracic Oncology

View full text Add to dashboard Cite

show abstract

“…Both poor performance status and comorbidity conditions are well known to be unfavorable prognostic factors . The patient died two months after diagnosis of metastases and four months after initial diagnosis of lung cancer.…”

Section: Discussionmentioning

confidence: 98%

“…7,8 The patient died two months after diagnosis of metastases and four months after initial diagnosis of lung cancer. His poor clinical course seems to be related with skeletal and peritoneal metastases, as well as poor performance status and comorbidity.…”

Section: Discussionmentioning

confidence: 99%

Squamous cell carcinoma of the lung with simultaneous metastases to peritoneum and skeletal muscle

Song

Kim

et al. 2014

Thoracic Cancer

View full text Add to dashboard Cite

Skeletal muscle and peritoneum are rare sites of metastases from lung cancer. We report a case of squamous cell lung cancer with concurrent metastases to skeletal muscle and peritoneum. A 71-year-old man was diagnosed with squamous cell carcinoma of the right lower lobe with metastasis to the right hilar lymph node at clinical stage T3N1M0. Because of poor performance status and comorbidity, he only received radiation therapy. Positron emission tomography-computed tomography for mid-assessment of response showed two abnormal hypermetabolic lesions in the peritoneum of the left upper quadrant area and the left thigh muscle. We performed a needle-approach biopsy in each lesion and found both of the lesions were metastases from lung cancer. The patient died after two months.

show abstract

“…Both determinants are often used for case mix correction. 33 If indicators are to be used to compare quality of care between hospitals, adjustment of the indicator scores might be needed. When more data are available, the prognostic value of patient characteristics for survival could be investigated.…”

Section: Discussionmentioning

confidence: 99%

Variation in Integrated Head and Neck Cancer Care: Impact of Patient and Hospital Characteristics

Overveld¹,

Takes²,

Braspenning³

et al. 2018

J Natl Compr Canc Netw

View full text Add to dashboard Cite

Background: Monitoring and effectively improving oncologic integrated care requires dashboard information based on quality registrations. The dashboard includes evidence-based quality indicators (QIs) that measure quality of care. This study aimed to assess the quality of current integrated head and neck cancer care with QIs, the variation between Dutch hospitals, and the influence of patient and hospital characteristics. Methods: Previously, 39 QIs were developed with input from medical specialists, allied health professionals, and patients' perspectives. QI scores were calculated with data from 1,667 curatively treated patients in 8 hospitals. QIs with a sample size of >400 patients were included to calculate reliable QI scores. We used multilevel analysis to explain the variation. Results: Current care varied from 29% for the QI about a case manager being present to discuss the treatment plan to 100% for the QI about the availability of a treatment plan. Variation between hospitals was small for the QI about patients discussed in multidisciplinary team meetings (adherence: 95%, range 88%-98%), but large for the QI about malnutrition screening (adherence: 50%, range 2%-100%). Higher QI scores were associated with lower performance status, advanced tumor stage, and tumor in the oral cavity or oropharynx at the patient level, and with more curatively treated patients (volume) at hospital level. Conclusions: Although the quality registration was only recently launched, it already visualizes hospital variation in current care. Four determinants were found to be influential: tumor stage, performance status, tumor site, and volume. More data are needed to assure stable results for use in quality improvement.

show abstract

General practitioner assessment of stage and performance status in lung cancer patients at a population level: Implications for prognosis and radiotherapy needs analyses

Cited by 10 publications

References 18 publications

Stage III Non–Small-Cell Lung Cancer: Population-Based Patterns of Treatment in British Columbia, Canada

Stage III Non–Small-Cell Lung Cancer: Population-Based Patterns of Treatment in British Columbia, Canada

Squamous cell carcinoma of the lung with simultaneous metastases to peritoneum and skeletal muscle

Variation in Integrated Head and Neck Cancer Care: Impact of Patient and Hospital Characteristics

Contact Info

Product

Resources

About